Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with Massdevice +3.
3. GI Dynamics sinks 13 percent on opening day
GI Dynamics (ASX:GID) had a less-than-auspicious début on the Australian stock exchange yesterday, where GID share prices dropped 13 percent in their first day of public trading.
2. Device training for FDA reviewers
The FDA launches its reviewer certification program to tighten device application times as Congress prepares to dig deeper into the watchdog agency’s med-tech review process.
1. AdvaMed warns of 400,000 lost jobs on FDA’s excise tax
Medical device industry lobby AdvaMed says that the new 2.3 percent excise tax, slated to go into effect in 2013, will be "the last straw on the camel’s back" for medical device companies trying to thrive in the struggling American economy.